The Discounted Cash Flow (DCF) valuation of Rhoen Klinikum AG (RHK.DE) is 14.86 EUR. With the latest stock price at 11.90 EUR, the upside of Rhoen Klinikum AG based on DCF is 24.9%.
Based on the latest price of 11.90 EUR and our DCF valuation, Rhoen Klinikum AG (RHK.DE) is a buy. buying RHK.DE stocks now will result in a potential gain of 24.9%.
| Range | Selected | |
| WACC / Discount Rate | 4.8% - 6.5% | 5.6% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 9.60 - 45.87 | 14.86 |
| Upside | -19.4% - 285.5% | 24.9% |